Keywords
Last Name
Institution

GUNAR K ZAGARS

TitleProfessor
InstitutionMD Anderson
DepartmentRadiation Oncology
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, Guadagnolo BA. Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 1; 93(1):158-65. PMID: 26130233.
      View in: PubMed
    2. Bishop AJ, Zagars GK, Moon BS, Lin PP, Lewis VO, Guadagnolo BA. Combined Limb-Sparing Surgery and Radiation Therapy to Treat Sarcomas of the Hands and Feet: Long-Term Cancer Outcomes and Morbidity. Int J Radiat Oncol Biol Phys. 2015 Aug 1; 92(5):1060-8. PMID: 26194681.
      View in: PubMed
    3. Guadagnolo BA, Prieto V, Weber R, Ross MI, Zagars GK. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014 May 1; 120(9):1361-8. PMID: 24142803.
      View in: PubMed
    4. Castle KO, Guadagnolo BA, Tsai CJ, Feig BW, Zagars GK. Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Jul 1; 86(3):585-90. PMID: 23628134.
      View in: PubMed
    5. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res. 2012; 2(1):25. PMID: 23272660.
      View in: PubMed
    6. Guadagnolo BA, Xu Y, Zagars GK, Cormier JN, Pollock RE, Feig BW, Giordano S, Buchholz TA, Shih YC. A population-based study of the quality of care in the diagnosis of large (?5 cm) soft tissue sarcomas. Am J Clin Oncol. 2012 Oct; 35(5):455-61. PMID: 21537147.
      View in: PubMed
    7. Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Cancer. 2011 Oct 15; 117(20):4747-55. PMID: 21446049.
      View in: PubMed
    8. Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck. 2011 May; 33(5):661-7. PMID: 20960566; PMCID: PMC4090937.
    9. Guadagnolo BA, Myers JN, Zagars GK. Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment. Head Neck. 2010 Jun; 32(6):708-13. PMID: 19787786.
      View in: PubMed
    10. Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009 Jul 15; 115(14):3262-70. PMID: 19382187.
      View in: PubMed
    11. Guadagnolo BA, Zagars GK. Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma. Lancet Oncol. 2009 Apr; 10(4):409-16. PMID: 19341972.
      View in: PubMed
    12. Beadle BM, Guadagnolo BA, Ballo MT, Lee JE, Gershenwald JE, Cormier JN, Mansfield PF, Ross MI, Zagars GK. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 2009 Apr 1; 73(5):1376-82. PMID: 18774657.
      View in: PubMed
    13. Guadagnolo BA, Zagars GK, Ballo MT, Strom SS, Pollock RE, Benjamin RS. Mortality after cure of soft-tissue sarcoma treated with conservation surgery and radiotherapy. Cancer. 2008 Jul 15; 113(2):411-8. PMID: 18506733.
      View in: PubMed
    14. Guadagnolo BA, Zagars GK, Ballo MT. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008 Jun 1; 71(2):441-7. PMID: 18068311.
      View in: PubMed
    15. Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MT. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007 Oct; 246(4):675-81; discussion 681-2. PMID: 17893504.
      View in: PubMed
    16. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Benjamin RS, Pollock RE. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):760-5. PMID: 17892916.
      View in: PubMed
    17. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PW, Benjamin RS, Pollock RE. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1173-80. PMID: 17689031.
      View in: PubMed
    18. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007 May 1; 25(13):1785-91. PMID: 17470870.
      View in: PubMed
    19. Lin PP, Pino ED, Normand AN, Deavers MT, Cannon CP, Ballo MT, Pisters PW, Pollock RE, Lewis VO, Zagars GK, Yasko AW. Periosteal margin in soft-tissue sarcoma. Cancer. 2007 Feb 1; 109(3):598-602. PMID: 17183556.
      View in: PubMed
    20. Torres MA, Ballo MT, Butler CE, Feig BW, Cormier JN, Lewis VO, Pollock RE, Pisters PW, Zagars GK. Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1124-9. PMID: 17208389.
      View in: PubMed
    21. Cannon CP, Ballo MT, Zagars GK, Mirza AN, Lin PP, Lewis VO, Yasko AW, Benjamin RS, Pisters PW. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer. 2006 Nov 15; 107(10):2455-61. PMID: 17036354.
      View in: PubMed
    22. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):158-63. PMID: 17084545.
      View in: PubMed
    23. Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, Cannon CP, Zagars GK, Pollock RE, Pisters PW. The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006 Sep; 13(9):1209-15. PMID: 16952046.
      View in: PubMed
    24. Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2006 Jan 1; 64(1):106-13. PMID: 16182463.
      View in: PubMed
    25. Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, Camacho LH, Hwu P, Ross MI. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol. 2004 Dec; 11(12):1079-84. PMID: 15576833.
      View in: PubMed
    26. Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80. PMID: 15310783.
      View in: PubMed
    27. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1461-7. PMID: 15050324.
      View in: PubMed
    28. Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol. 2004 Feb 15; 22(4):640-7. PMID: 14726503.
      View in: PubMed
    29. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 1; 57(3):739-47. PMID: 14529779.
      View in: PubMed
    30. Little DJ, Kuban DA, Levy LB, Zagars GK, Pollack A. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology. 2003 Oct; 62(4):707-13. PMID: 14550448.
      View in: PubMed
    31. Caudell JJ, Ballo MT, Zagars GK, Lewis VO, Weber KL, Lin PP, Marco RA, El-Naggar AK, Benjamin RS, Yasko AW. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003 Sep 1; 57(1):158-65. PMID: 12909228.
      View in: PubMed
    32. Pisters PW, Ballo MT, Fenstermacher MJ, Feig BW, Hunt KK, Raymond KA, Burgess MA, Zagars GK, Pollock RE, Benjamin RS, Patel SR. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7. PMID: 12915599.
      View in: PubMed
    33. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003 Jun 1; 56(2):482-8. PMID: 12738324.
      View in: PubMed
    34. Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2003 Jun 1; 56(2):473-81. PMID: 12738323.
      View in: PubMed
    35. Patel SR, Zagars GK, Pisters PW. The follow-up of adult soft-tissue sarcomas. Semin Oncol. 2003 Jun; 30(3):413-6. PMID: 12870143.
      View in: PubMed
    36. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003 May 15; 97(10):2544-53. PMID: 12733154.
      View in: PubMed
    37. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003 May 15; 97(10):2530-43. PMID: 12733153.
      View in: PubMed
    38. Zagars GK, Ballo MT. Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned. Int J Radiat Oncol Biol Phys. 2003 May 1; 56(1):21-7. PMID: 12694820.
      View in: PubMed
    39. Pollack A, Cowen D, Troncoso P, Zagars GK, von Eschenbach AC, Meistrich ML, McDonnell T. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x. Cancer. 2003 Apr 1; 97(7):1630-8. PMID: 12655519.
      View in: PubMed
    40. Ballo MT, Zagars GK. Radiation therapy for soft tissue sarcoma. Surg Oncol Clin N Am. 2003 Apr; 12(2):449-67, vii. PMID: 12916463.
      View in: PubMed
    41. Ballo MT, Bonnen MD, Garden AS, Myers JN, Gershenwald JE, Zagars GK, Schechter NR, Morrison WH, Ross MI, Kian Ang K. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer. 2003 Apr 1; 97(7):1789-96. PMID: 12655537.
      View in: PubMed
    42. Millar J, Williams S. In regard to Pollack et al., prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. IJROBP 2002;53:1097-1105. Int J Radiat Oncol Biol Phys. 2003 Apr 1; 55(5):1461; author reply 1461-2. PMID: 12654464.
      View in: PubMed
    43. Kagan AR, Schulz RJ. A commentary on dose escalation and bNED in prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):1151; author reply 1151-2. PMID: 12605997.
      View in: PubMed
    44. Ballo MT, Gershenwald JE, Zagars GK, Lee JE, Mansfield PF, Strom EA, Bedikian AY, Kim KB, Papadopoulos NE, Prieto VG, Ross MI. Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol. 2002 Dec 1; 20(23):4555-8. PMID: 12454112.
      View in: PubMed
    45. Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys. 2002 Nov 1; 54(3):677-85. PMID: 12377318.
      View in: PubMed
    46. Pollack A, Kuban DA, Zagars GK. Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer. Urology. 2002 Sep; 60(3 Suppl 1):22-30; discussion 30-1. PMID: 12231041.
      View in: PubMed
    47. Lin PP, Guzel VB, Pisters PW, Zagars GK, Weber KL, Feig BW, Pollock RE, Yasko AW. Surgical management of soft tissue sarcomas of the hand and foot. Cancer. 2002 Aug 15; 95(4):852-61. PMID: 12209730.
      View in: PubMed
    48. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53(5):1097-105. PMID: 12128107.
      View in: PubMed
    49. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS, Benjamin RS. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002 Jul 15; 95(2):377-88. PMID: 12124838.
      View in: PubMed
    50. Cowen D, Troncoso P, Khoo VS, Zagars GK, von Eschenbach AC, Meistrich ML, Pollack A. Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy. Clin Cancer Res. 2002 May; 8(5):1148-54. PMID: 12006531.
      View in: PubMed
    51. Ballo MT, Strom EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, Lee JE, Gershenwald JE, Ross MI. Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):964-72. PMID: 11958890.
      View in: PubMed
    52. Ahmad SA, Patel SR, Ballo MT, Baker TP, Yasko AW, Wang X, Feig BW, Hunt KK, Lin PP, Weber KL, Chen LL, Zagars GK, Pollock RE, Benjamin RS, Pisters PW. Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002 Jan 15; 20(2):521-7. PMID: 11786582.
      View in: PubMed
    53. Zagars GK, Pollack A. Radiotherapy for stage II testicular seminoma. Int J Radiat Oncol Biol Phys. 2001 Nov 1; 51(3):643-9. PMID: 11597804.
      View in: PubMed
    54. Callister MD, Ballo MT, Pisters PW, Patel SR, Feig BW, Pollock RE, Benjamin RS, Zagars GK. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 1; 51(2):384-91. PMID: 11567812.
      View in: PubMed
    55. Ballo MT, Zagars GK, Pisters PW, Feig BW, Patel SR, von Eschenbach AC. Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct; 166(4):1306-10. PMID: 11547063.
      View in: PubMed
    56. Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PW. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5. PMID: 11745234.
      View in: PubMed
    57. Zagars GK, Pollack A, von Eschenbach AC. Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. Urology. 2001 Aug; 58(2):233-9. PMID: 11489709.
      View in: PubMed
    58. Pollack A, Zagars GK, Smith LG, Lee JJ, von Eschenbach AC, Antolak JA, Starkschall G, Rosen I. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 2000 Dec 1; 18(23):3904-11. PMID: 11099319.
      View in: PubMed
    59. Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK. Primary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000 Oct 1; 89(7):1502-11. PMID: 11013364.
      View in: PubMed
    60. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000 Oct 1; 48(3):635-42. PMID: 11020558.
      View in: PubMed
    61. May CA, Tamaki K, Neumann R, Wilson G, Zagars G, Pollack A, Dubrova YE, Jeffreys AJ, Meistrich ML. Minisatellite mutation frequency in human sperm following radiotherapy. Mutat Res. 2000 Sep 20; 453(1):67-75. PMID: 11006413.
      View in: PubMed
    62. Kelly JF, Pollack A, Zagars GK. Serum testosterone is not a correlate of prostate cancer lymph node involvement, but does predict biochemical failure for lymph node positive disease. Urol Oncol. 2000 Mar-Apr; 5(2):78-84. PMID: 21227292.
      View in: PubMed
    63. Pollack A, Ashoori F, Sikes C, Joon DL, von Eschenbach AC, Zagars GK, Meistrich ML. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions. Int J Radiat Oncol Biol Phys. 2000 Jan 1; 46(1):153-8. PMID: 10656387.
      View in: PubMed
    64. Khoo VS, Pollack A, Cowen D, Joon DL, Patel N, Terry NH, Zagars GK, von Eschenbach AC, Meistrich ML, Troncoso P. Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy. Prostate. 1999 Nov 1; 41(3):166-72. PMID: 10517874.
      View in: PubMed
    65. Fleming JB, Berman RS, Cheng SC, Chen NP, Hunt KK, Feig BW, Respondek PM, Yasko AW, Pollack A, Patel SR, Burgess MA, Papadopoulos NE, Plager C, Zagars G, Benjamin RS, Pollock RE, Pisters PW. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80. PMID: 10561352.
      View in: PubMed
    66. Zagars GK, Pollack A, Smith LG. Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1999 Jul 1; 44(4):809-19. PMID: 10386637.
      View in: PubMed
    67. Liebross RH, Pollack A, Lankford SP, Zagars GK, von Eschenbach AC, Geara FB. Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome. Cancer. 1999 Apr 1; 85(7):1577-85. PMID: 10193949.
      View in: PubMed
    68. Pollack A, Zagars GK, Rosen II. Prostate cancer treatment with radiotherapy: maturing methods that minimize morbidity. Semin Oncol. 1999 Apr; 26(2):150-61. PMID: 10597726.
      View in: PubMed
    69. Hanus MC, Zagars GK, Pollack A. Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys. 1999 Jan 15; 43(2):379-83. PMID: 10030265.
      View in: PubMed
    70. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999 Jan; 17(1):158-67. PMID: 10458229.
      View in: PubMed
    71. Ballo MT, Zagars GK, Pollack A. Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys. 1998 Dec 1; 42(5):1007-14. PMID: 9869223.
      View in: PubMed
    72. Zagars GK, Pollack A, Pettaway CA. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys. 1998 Oct 1; 42(3):517-23. PMID: 9806509.
      View in: PubMed
    73. Liebross RH, Pollack A, Lankford SP, von Eschenbach AC, Zagars GK. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy. Urology. 1998 Oct; 52(4):647-52. PMID: 9763087.
      View in: PubMed
    74. Antolak JA, Rosen II, Childress CH, Zagars GK, Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 1998 Oct 1; 42(3):661-72. PMID: 9806528.
      View in: PubMed
    75. Pollack A, Zagars GK, Goswitz MS, Pollock RA, Feig BW, Pisters PW. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys. 1998 Oct 1; 42(3):563-72. PMID: 9806516.
      View in: PubMed
    76. Daniell HW. Regarding Zagars and Pollack. Int J Radiat Oncol Biol Phys. 1998 Jul 1; 41(4):973-4. PMID: 9652869.
      View in: PubMed
    77. Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology. 1998 Jun; 51(6):991-7. PMID: 9609638.
      View in: PubMed
    78. Pollack A, Zagars GK. Androgen ablation in addition to radiation therapy for prostate cancer: is there true benefit? Semin Radiat Oncol. 1998 Apr; 8(2):95-106. PMID: 9516590.
      View in: PubMed
    79. Ballo MT, Zagars GK, Pisters P, Pollack A. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys. 1998 Mar 1; 40(4):823-7. PMID: 9531366.
      View in: PubMed
    80. Pollack A, Zagars GK. External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up? Urology. 1998 Feb; 51(2):258-64. PMID: 9495708.
      View in: PubMed
    81. Powell S. Is there a role for radiation therapy for the management of phyllodes tumor of the breast? Radiat Oncol Investig. 1998; 6(6):289-90. PMID: 9885946.
      View in: PubMed
    82. Chaney AW, Pollack A, McNeese MD, Zagars GK. Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Investig. 1998; 6(6):264-7. PMID: 9885942.
      View in: PubMed
    83. Pollack A, Zagars GK. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 1997 Dec 1; 39(5):1011-8. PMID: 9392538.
      View in: PubMed
    84. Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res. 1997 Oct; 3(10):1823-9. PMID: 9815569.
      View in: PubMed
    85. Pollack A, Czerniak B, Zagars GK, Hu SX, Wu CS, Dinney CP, Chyle V, Benedict WF. Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1997 Oct 1; 39(3):687-95. PMID: 9336151.
      View in: PubMed
    86. Zagars GK, Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol. 1997 Sep; 44(3):213-21. PMID: 9380819.
      View in: PubMed
    87. Zagars GK, Pollack A, von Eschenbach AC. Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation. Cancer. 1997 Aug 15; 80(4):764-75. PMID: 9264361.
      View in: PubMed
    88. Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997 Aug 1; 39(1):85-9. PMID: 9300743.
      View in: PubMed
    89. Joon DL, Hasegawa M, Sikes C, Khoo VS, Terry NH, Zagars GK, Meistrich ML, Pollack A. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation. Int J Radiat Oncol Biol Phys. 1997 Jul 15; 38(5):1071-7. PMID: 9276374.
      View in: PubMed
    90. Pollack A, Joon DL, Wu CS, Sikes C, Hasegawa M, Terry NH, White RA, Zagars GK, Meistrich ML. Quiescence in R3327-G rat prostate tumors after androgen ablation. Cancer Res. 1997 Jun 15; 57(12):2493-500. PMID: 9192831.
      View in: PubMed
    91. Lankford SP, Pollack A, Zagars GK. Prostate-specific antigen cancer volume: a significant prognostic factor in prostate cancer patients at intermediate risk of failing radiotherapy. Int J Radiat Oncol Biol Phys. 1997 May 1; 38(2):327-33. PMID: 9226319.
      View in: PubMed
    92. Pollack A, Troncoso P, Zagars GK, von Eschenbach AC, Mak AC, Wu CS, Terry NH. The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation. Prostate. 1997 Apr 1; 31(1):21-8. PMID: 9108882.
      View in: PubMed
    93. Zagars GK, Pollack A, von Eschenbach AC. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer. 1997 Apr 1; 79(7):1370-80. PMID: 9083160.
      View in: PubMed
    94. Zagars GK, Pollack A, von Eschenbach AC. Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancer. Urology. 1997 Mar; 49(3):327-34. PMID: 9123693.
      View in: PubMed
    95. Pollack A, Zagars GK, Cole CJ, Dinney CP, Swanson DA, Grossman HB. Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1997 Jan 1; 37(1):41-9. PMID: 9054875.
      View in: PubMed
    96. Zagars GK, Goswitz MS, Pollack A. Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996 Sep 1; 36(2):311-9. PMID: 8892453.
      View in: PubMed
    97. Chyle V, Zagars GK, Wheeler JA, Wharton JT, Delclos L. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 1996 Jul 15; 35(5):891-905. PMID: 8751398.
      View in: PubMed
    98. Chyle V, Pollack A, Czerniak B, Stephens LC, Zagars GK, Terry NH, Meyn RE. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1996 May 1; 35(2):281-7. PMID: 8635934.
      View in: PubMed
    99. Pollack A, Zagars GZ. Radiotherapy for stage T3b transitional cell carcinoma of the bladder. Semin Urol Oncol. 1996 May; 14(2):86-95. PMID: 8734736.
      View in: PubMed
    100. Pollack A, Zagars GK. Radiotherapy vs. surgery for prostate cancer: an age old question. Int J Radiat Oncol Biol Phys. 1996 May 1; 35(2):407-9. PMID: 8635950.
      View in: PubMed
    101. Pollack A, Lankford S, Zagars GK, Babaian RJ. Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy. Cancer. 1996 Apr 15; 77(8):1515-23. PMID: 8608537.
      View in: PubMed
    102. Zagars GK, Mullen JR, Pollack A. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):983-94. PMID: 8600111.
      View in: PubMed
    103. Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology. 1996 Mar; 47(3):305-10. PMID: 8633392.
      View in: PubMed
    104. Pollack A, Zagars GK, Starkschall G, Childress CH, Kopplin S, Boyer AL, Rosen II. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys. 1996 Feb 1; 34(3):555-64. PMID: 8621278.
      View in: PubMed
    105. Pollack A, Zagars GK, Cole CJ, Dinney CP, Swanson DA, Grossman HB. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol. 1995 Dec; 154(6):2059-63; discussion 2063-4. PMID: 7500458.
      View in: PubMed
    106. Lankford SP, Pollack A, Zagars GK. Radiotherapy for regionally localized hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys. 1995 Nov 1; 33(4):907-12. PMID: 7591901.
      View in: PubMed
    107. Zagars GK, Pollack A, von Eschenbach AC. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 1995 Aug 30; 33(1):23-35. PMID: 7543892.
      View in: PubMed
    108. Zagars GK, Pollack A, Kavadi VS, von Eschenbach AC. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1995 May 15; 32(2):293-306. PMID: 7538498.
      View in: PubMed
    109. Cole CJ, Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys. 1995 May 15; 32(2):331-40. PMID: 7751174.
      View in: PubMed
    110. Pollack A, Zagars GK, Kopplin S. Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):13-20. PMID: 7536720.
      View in: PubMed
    111. Zagars GK, Kavadi VS, Pollack A, von Eschenbach AC, Sands ME. The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M? Int J Radiat Oncol Biol Phys. 1995 Apr 30; 32(1):21-32. PMID: 7536722.
      View in: PubMed
    112. Hall MC, Navone NM, Troncoso P, Pollack A, Zagars GK, von Eschenbach AC, Conti CJ, Chung LW. Frequency and characterization of p53 mutations in clinically localized prostate cancer. Urology. 1995 Mar; 45(3):470-5. PMID: 7879337.
      View in: PubMed
    113. Zagars GK, Pollack A. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome. Urology. 1995 Mar; 45(3):476-83. PMID: 7533459.
      View in: PubMed
    114. Zagars GK, Pollack A, von Eschenbach AC, Ayala AG. Gleason grade and other prognostic factors--response to Drs. Hammond and Grignon. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):435. PMID: 7530702.
      View in: PubMed
    115. Pollack A, Zagars GK, Sands ME. Local treatment for prostate cancer: 90 years later--response to M. V. Pilepich. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):436. PMID: 7836101.
      View in: PubMed
    116. Zagars GK, Ayala AG, von Eschenbach AC, Pollack A. The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1995 Jan 15; 31(2):237-45. PMID: 7836075.
      View in: PubMed
    117. Peters LJ, Zagars GK. Neutron therapy in prostate cancer--is the therapeutic ratio improved? Int J Radiat Oncol Biol Phys. 1995 Jan 1; 31(1):204-5. PMID: 7995760.
      View in: PubMed
    118. Benjamin RS, Pollock RE, Zagars GK. Soft tissue sarcomas of the extremities: continuing challenges for a multidisciplinary team. Cancer Invest. 1995; 13(1):137-8. PMID: 7834469.
      View in: PubMed
    119. Sands ME, Pollack A, Zagars GK. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation. Int J Radiat Oncol Biol Phys. 1995 Jan 1; 31(1):13-9. PMID: 7527796.
      View in: PubMed
    120. Hall MC, Troncoso P, Pollack A, Zhau HY, Zagars GK, Chung LW, von Eschenbach AC. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology. 1994 Dec; 44(6):869-75. PMID: 7527168.
      View in: PubMed
    121. Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients. Cancer. 1994 Nov 15; 74(10):2819-27. PMID: 7954243.
      View in: PubMed
    122. Pollack A, Zagars GK, el-Naggar AK, Terry NH. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. Urology. 1994 Nov; 44(5):711-8. PMID: 7526527.
      View in: PubMed
    123. Zagars GK. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy. J Urol. 1994 Nov; 152(5 Pt 2):1786-91. PMID: 7523725.
      View in: PubMed
    124. Shipley WU, Zietman AL, Hanks GE, Coen JJ, Caplan RJ, Won M, Zagars GK, Asbell SO. Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. J Urol. 1994 Nov; 152(5 Pt 2):1799-805. PMID: 7933239.
      View in: PubMed
    125. Mullen JR, Zagars GK. Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol. 1994 Oct; 33(1):23-30. PMID: 7878206.
      View in: PubMed
    126. Pollack A, Zagars GK, Swanson DA. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):267-77. PMID: 7928456.
      View in: PubMed
    127. Kavadi VS, Zagars GK, Pollack A. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: prognostic implications. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):279-87. PMID: 7523340.
      View in: PubMed
    128. Geara FB, Zagars GK, Pollack A. Influence of initial presentation on treatment outcome of clinically localized prostate cancer treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):331-7. PMID: 7523344.
      View in: PubMed
    129. Sands ME, Zagars GK, Pollack A, von Eschenbach AC. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer. Urology. 1994 Aug; 44(2):215-20. PMID: 7519381.
      View in: PubMed
    130. Pollack A, Zagars GK, Kavadi VS. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer. 1994 Jul 15; 74(2):670-8. PMID: 7518341.
      View in: PubMed
    131. Dimopoulos MA, Yau JC, Huan SD, Jagannath S, Spitzer G, Spinolo JA, Zagars GK, LeMaistre CF, Dicke KA, Zander AR. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation. Am J Hematol. 1994 Jun; 46(2):82-6. PMID: 8172200.
      View in: PubMed
    132. Zagars GK, Sands ME, Pollack A, von Eschenbach AC. Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome. J Urol. 1994 May; 151(5):1330-3. PMID: 7512663.
      View in: PubMed
    133. Zagars GK, Geara FB, Pollack A, von Eschenbach AC. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy. Cancer. 1994 Apr 1; 73(7):1904-12. PMID: 7511040.
      View in: PubMed
    134. Pollack A, Zagars GK, el-Naggar AK, Gauwitz MD, Terry NH. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Cancer. 1994 Apr 1; 73(7):1895-903. PMID: 7511039.
      View in: PubMed
    135. Gauwitz MD, Pollack A, el-Naggar AK, Terry NH, von Eschenbach AC, Zagars GK. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1994 Mar 1; 28(4):821-8. PMID: 8138434.
      View in: PubMed
    136. Zagars GK, Pollack A. The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatment. Radiother Oncol. 1994 Feb; 30(2):121-7. PMID: 7514308.
      View in: PubMed
    137. Zagars GK. Serum PSA as a tumor marker for patients undergoing definitive radiation therapy. Urol Clin North Am. 1993 Nov; 20(4):737-47. PMID: 7505982.
      View in: PubMed
    138. Zagars GK. The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1993 Sep 1; 27(1):39-45. PMID: 7690017.
      View in: PubMed
    139. Zagars GK, von Eschenbach AC, Ayala AG. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer. 1993 Sep 1; 72(5):1709-25. PMID: 7688659.
      View in: PubMed
    140. Zagars GK, Pollack A. The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer. Cancer. 1993 Aug 1; 72(3):832-42. PMID: 7687516.
      View in: PubMed
    141. Zagars GK, von Eschenbach AC. Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. Cancer. 1993 Jul 15; 72(2):538-48. PMID: 7686443.
      View in: PubMed
    142. Dosmann MA, Zagars GK. Post-orchiectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys. 1993 Jun 15; 26(3):381-90. PMID: 7685748.
      View in: PubMed
    143. Wheeler JA, Zagars GK, Ayala AG. Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progression. Cancer. 1993 Jun 1; 71(11):3783-7. PMID: 8490929.
      View in: PubMed
    144. Zagars GK, von Eschenbach AC, Johnson DE. Radiotherapy versus surgery for stage C prostate cancer. Urology. 1993 Jun; 41(6):605. PMID: 8517003.
      View in: PubMed
    145. Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra. Results of radiation therapy. Cancer. 1993 May 15; 71(10):3102-8. PMID: 8490839.
      View in: PubMed
    146. Zagars GK. Stage I testicular seminoma following orchidectomy--to treat or not to treat. Eur J Cancer. 1993; 29A(14):1923-4. PMID: 8280482.
      View in: PubMed
    147. Gauwitz MD, Zagars GK. Treatment of seminoma arising in cryptorchid testes. Int J Radiat Oncol Biol Phys. 1992; 24(1):153-9. PMID: 1355081.
      View in: PubMed
    148. Zagars GK. Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1992; 23(1):47-53. PMID: 1374065.
      View in: PubMed
    149. Zagars GK, von Eschenbach AC, Ayala AG, Schultheiss TE, Sherman NE. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer. 1991 Dec 1; 68(11):2370-7. PMID: 1933773.
      View in: PubMed
    150. Greskovich FJ, Zagars GK, Sherman NE, Johnson DE. Complications following external beam radiation therapy for prostate cancer: an analysis of patients treated with and without staging pelvic lymphadenectomy. J Urol. 1991 Sep; 146(3):798-802. PMID: 1908530.
      View in: PubMed
    151. Zagars GK, Sherman NE, Babaian RJ. Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer. 1991 Jan 15; 67(2):412-20. PMID: 1702349.
      View in: PubMed
    152. Talbert ML, Zagars GK, Sherman NE, Romsdahl MM. Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ankle, and foot. Cancer. 1990 Dec 15; 66(12):2482-91. PMID: 2249188.
      View in: PubMed
    153. Carlton JC, Zagars GK, Oswald MJ. The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1383-8. PMID: 2262362.
      View in: PubMed
    154. Jagannath S, Barlogie B, Dicke K, Alexanian R, Zagars G, Cheson B, Lemaistre FC, Smallwood L, Pruitt K, Dixon DO. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood. 1990 Nov 1; 76(9):1860-6. PMID: 2224133.
      View in: PubMed
    155. Babaian RJ, Zagars GK, Ayala AG. Radiation therapy of stage C prostate cancer: significance of Gleason grade to survival. Semin Urol. 1990 Nov; 8(4):225-31. PMID: 2284529.
      View in: PubMed
    156. Sherman NE, Romsdahl M, Evans H, Zagars G, Oswald MJ. Desmoid tumors: a 20-year radiotherapy experience. Int J Radiat Oncol Biol Phys. 1990 Jul; 19(1):37-40. PMID: 2380093.
      View in: PubMed
    157. Yau JC, LeMaistre CF, Zagars GK, Williams LA, Meneghetti CM, Luke DR, Dunphy FR, Spinolo JA, Jagannath S, Spitzer G, et al. Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host disease. Bone Marrow Transplant. 1990 Apr; 5(4):269-72. PMID: 2337738.
      View in: PubMed
    158. Swanson DA, Liles A, Zagars GK. Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J Urol. 1990 Jan; 143(1):37-40. PMID: 2294257.
      View in: PubMed
    159. Zagars GK, von Eschenbach AC, Johnson DE. The influence of pelvic node irradiation on prognosis. Int J Radiat Oncol Biol Phys. 1989 Mar; 16(3):882. PMID: 2921182.
      View in: PubMed
    160. Zagars GK, Johnson DE, von Eschenbach AC, Hussey DH. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study. Int J Radiat Oncol Biol Phys. 1988 Jun; 14(6):1085-91. PMID: 3133327.
      View in: PubMed
    161. Barkley HT, Martin RG, Romsdahl MM, Lindberg R, Zagars GK. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys. 1988 Apr; 14(4):693-9. PMID: 3350724.
      View in: PubMed
    162. Zagars GK, von Eschenbach AC, Johnson DE, Oswald MJ. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1988 Apr; 14(4):701-9. PMID: 3350725.
      View in: PubMed
    163. Babaian RJ, Zagars GK. Testicular seminoma: the M. D. Anderson experience. An analysis of pathological and patient characteristics, and treatment recommendations. J Urol. 1988 Feb; 139(2):311-4. PMID: 3339730.
      View in: PubMed
    164. Zagars GK. Seminoma with bulky abdominal disease. Int J Radiat Oncol Biol Phys. 1988 Feb; 14(2):395-7. PMID: 3123434.
      View in: PubMed
    165. Mills MD, Fuller LM, Zagars GK, McNeese MD. Spinal cord dose reduction using an anterior 13 MeV electron field situated between a split anterior 60Co supraclavicular field. Int J Radiat Oncol Biol Phys. 1987 Oct; 13(10):1571-5. PMID: 3114183.
      View in: PubMed
    166. Zagars GK, von Eschenbach AC, Johnson DE, Oswald MJ. Stage C adenocarcinoma of the prostate. An analysis of 551 patients treated with external beam radiation. Cancer. 1987 Oct 1; 60(7):1489-99. PMID: 3113715.
      View in: PubMed
    167. Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood. 1987 Sep; 70(3):869-72. PMID: 3304465.
      View in: PubMed
    168. Schultheiss TE, Zagars GK, Peters LJ. An explanatory hypothesis for early- and late-effect parameter values in the LQ model. Radiother Oncol. 1987 Jul; 9(3):241-8. PMID: 3628858.
      View in: PubMed
    169. Zagars GK, Schultheiss TE, Peters LJ. Inter-tumor heterogeneity and radiation dose-control curves. Radiother Oncol. 1987 Apr; 8(4):353-61. PMID: 3588999.
      View in: PubMed
    170. Zagars GK, Babaian RJ. The role of radiation in stage II testicular seminoma. Int J Radiat Oncol Biol Phys. 1987 Feb; 13(2):163-70. PMID: 3818384.
      View in: PubMed
    171. Zagars GK, Babaian RJ. Stage I testicular seminoma: rationale for postorchiectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1987 Feb; 13(2):155-62. PMID: 3818383.
      View in: PubMed
    172. Constine LS, Zagars G, Rubin P, Kligerman M. Protection by WR-2721 of human bone marrow function following irradiation. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1505-8. PMID: 2428794.
      View in: PubMed
    173. Spitzer G, Jagannath S, Dicke KA, Armitage J, Zander AR, Vellekoop L, Horwitz L, Cabanillas F, Zagars GK, Velasquez WS. High-dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies. Eur J Cancer Clin Oncol. 1986 Jun; 22(6):677-84. PMID: 3527715.
      View in: PubMed
    174. Vellekoop L, Zander AR, Kantarjian HM, Jagannath S, Hester JP, Trujillo J, McCredie KB, Zagars G, Spitzer G, Dicke KA. Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia. J Clin Oncol. 1986 Jun; 4(6):906-11. PMID: 3519881.
      View in: PubMed
    175. Rubin P, Zagars G, Chuang C, Thomas EM. Hodgkin's disease: is there a price for successful treatment? A 25-year experience. Int J Radiat Oncol Biol Phys. 1986 Feb; 12(2):153-66. PMID: 3949565.
      View in: PubMed
    176. Zagars G, Rubin P. Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy. Cancer. 1985 Oct 15; 56(8):1905-12. PMID: 4027927.
      View in: PubMed
    177. Zagars G, Rubin P. Laparotomy-staged IA versus IIA Hodgkin's disease. A comparative study with evaluation of prognostic factors for stage IIA disease. Cancer. 1985 Aug 15; 56(4):864-73. PMID: 4016677.
      View in: PubMed
    178. Zagars G, Salazar OM, Baird M, Phillips TL, Rubin P. Misonidazole and hemibody irradiation in the palliation of widespread metastases. Final report of an RTOG study. Am J Clin Oncol. 1985 Aug; 8(4):293-7. PMID: 3909800.
      View in: PubMed
    179. Rubin P, Salazar O, Zagars G, Constine LS, Keys H, Poulter CA, Van Ess JD. Systemic hemibody irradiation for overt and occult metastases. Cancer. 1985 May 1; 55(9 Suppl):2210-21. PMID: 2579726.
      View in: PubMed
    180. Coleman CN, Wasserman TH, Phillips TL, Strong JM, Urtasun RC, Schwade JG, Johnson RJ, Zagars G. Initial pharmacology and toxicology of intravenous desmethylmisonidazole. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr; 8(3-4):371-5. PMID: 7107354.
      View in: PubMed
    181. Salazar OM, Rubin P, Hendrickson FR, Poulter C, Zagars G, Feldman MI, Asbell S, Doss L. Single-dose half-body irradiation for the palliation of multiple bone metastases from solid tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1981 Jun; 7(6):773-81. PMID: 6169699.
      View in: PubMed
    182. Misonidazole and hemi-body irradiation for the palliation of widespread symptomatic metastases. Progress report of an on-going RTOG phase I/II study. International Journal of Radiation Oncology Biology Physics. 6:1390.
    183. Androgen-ablated node-positive prostate cancer. International journal of radiation oncology, biology, physics. 32:896-897.
    184. Reply to. Radiotherapy and Oncology. 12:85.
    185. Discussion. Journal of Urology. 152:1813-1815.
    186. Treatment-related fractures after combined modality therapy for soft tissue sarcomas of the proximal lower extremity. Practical Radiation Oncology. 6:194-200.
    187. Early androgen ablation and radiation therapy for unfavorable local-regional prostate cancer. Cancer Research Therapy and Control. 7:211-215.
    188. Malignant Peripheral Nerve Sheath Tumors. American Journal of Clinical Oncology: Cancer Clinical Trials.
    189. Comparison of the response and toxicity of total body irradiation vs chlorambucil and prednisone for remission induction of chronic lymphocytic leukemia (active) an ECOG study. International Journal of Radiation Oncology Biology Physics. 6:1351-1352.
    190. External beam radiotherapy for stage T1/T2 prostate cancer. Radiology. 208:276.
    191. PSA level as predictor in prostate cancer. Journal of the American Osteopathic Association. 93:904.
    192. The Fiveash/Sandler Article Reviewed. Oncology. 12:1217-1221.
    193. Radiotherapy for clinically localized cancer of the prostate. Cancer Bulletin. 45:411-417.
    194. Response to editorial by Dr. Gillian M. Thomas. International journal of radiation oncology, biology, physics. 26:549.
    ZAGARS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description